Date Posted: Mar 7, 2019
Application Deadline: Open Until Filled
We have an opening for a postdoctoral scholar in cancer metabolism research. The candidate will be joining a collaborative research environment between the Labs of Eric Haura and John Cleveland at Moffitt. We are looking for a highly motivated and independent postdoctoral research fellow who is interested in working on a project related to metabolic vulnerabilities in small cell lung cancer.
The Ideal Candidate:
Successful candidates will have a publication track record demonstrating a strong background\ in cancer metabolism or cellular metabolism and interests in translational research. Prior experience is required with some of the following techniques: mammalian cell culture, cell based viability assays, metabolite and metabolic enzymatic assays, immunoblot analysis, flow cytometry analysis, Seahorse metabolic flux analysis, metabolic radiolabeling assays, mass spectrometry-based metabolomic measurement and tracing assays, and in vivo mouse work. Candidates with prior research experience in cellular metabolism of cancer will be given preference.
This individual will design, conduct and interpret correlative experiments using human lung cancer cell lines, mouse models, and human tumor samples. This individual will identify and validate predicted vulnerabilities from existing proteomic and metabolomics data. The candidate will join a productive, energetic team of molecular biologists, bioinformaticians, and clinicians within our group.
Credentials and Qualifications:
M.D. or PhD in Molecular Biology, Immunology, Biochemistry, or relevant field.
Interested applicants should send their current CV with recent publications and contact information for three references to Dr. Eric Haura at Eric.Haura@moffitt.org
Moffitt Cancer Center is a premier cancer research institution in the United States. Built in an attractive location, Moffitt is the only NCI-designated Cancer Center in Florida and one of the top institutions in systems medicine and personalized cancer therapy. Moffitt features a number of high-quality core facilities equipped with state-of-the-art instrumentation and a cluster of expertise particularly in adoptive cell therapies.
H. Lee Moffitt Cancer Center & Research Institute is an equal opportunity, affirmative action employer, and a drug free workplace